Next-Generation Factor XIa Cuts Recurrent Stroke Risk by 26%

By News Health
2 hours Ago

(MedPage Today) — NEW ORLEANS — Factor XIa (FXIa) inhibition for secondary stroke prevention got a major win in the large OCEANIC-STROKE placebo-controlled trial.
Among adults with acute non-cardioembolic ischemic stroke or high-risk transient…

Source link : https://www.medpagetoday.com/meetingcoverage/isc/119756

Author :

Publish date : 2026-02-05 20:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Novo Nordisk Calls Semaglutide Knockoff Illegal, Risky

Study Supports Personalized Surveillance for Colon Polyp Recurrence Risk

Hims & Hers Launches Copy of Wegovy Pill, Prompting Legal Threats

Dozens of Illness Reports Linked to Infant Formula Recalls

PAHO Issues Alert as Measles Cases Surge Across the Americas

Fellow Nurses: Was Alexis Lawler Treated Fairly?